Antiques Roadshow star Theo Burrell has been candidly sharing updates on her cancer diagnosis ever since she was diagnosed ...

A Lisbon man is battling a rare brain cancer. It’ll be a long road to recovery and the treatment is going to be costly.

Targeting and customizing blood vessels in tumors to increase T cell infiltration and maintain their function may represent the next breakthrough in cancer therapy.

A research team at Lund University in Sweden has discovered a certain type of cell—foam cells—in patients with the aggressive ...

The VASC-IMMUNE project addresses the interaction between endothelial and immune cells focusing on both melanoma, a malignant ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival ...

Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this ...

As a surgical strategy for the management of glioblastoma, lobectomy improves overall survival and PFS by approximately 1 year, demonstrating its promise.

Phase 3 trial results showed that adding veliparib to temozolomide did not significantly improve overall or progression-free survival in newly diagnosed, MGMT-hypermethylated glioblastoma.

In July, the company announced results from the Phase II/III clinical trial, GBM-AGILE, in which newly diagnosed unmethylated patients with glioblastoma treated with paxalisib showed clinically ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

Glioblastoma, a highly aggressive brain cancer, poses survival challenges with current treatments like surgery and chemotherapy. Immunotherapy offers hope by leveraging the immune system against ...